ABSTRACT
INTRODUCTION
Neuroblastoma is the commonest extracranial pediatric solid tumor and the most frequent solid neoplasm in the first year of life (1) .It arises from the precursors of the sympathetic nervous system. The most common primary sites of neuroblastoma are the adrenal gland (40%), paraspinal ganglia in the retroperitoneum (25%), mediastinum (15%), neck (5%) and pelvis (3%) (2, 3) . The natural history of NB is extremely heterogeneous, but is usually predictable from clinical and biologic features (4) .Treatment and outcome of neuroblastoma depend on assessment of risk status and on stage of the disease (3) . Imaging by Computed Tomography (CT) plays an important role in diagnosis, staging and follow up of NB. Most protocols include regular CT assessment, to determine efficacy of therapy and thuspredict patient's prognosis (5) . For a long time; the International Neuroblastoma Staging System (INSS) was used for staging (6) . However, this post surgical staging system depends on surgical skill; it can't be applied uniformly in different centers, or used for pretreatment risk classification (3) . The International Neuroblastoma Risk Group Staging System (INRGSS) is a recent pre treatment staging system for NB, based on the imaging results taken by CT or MRI before surgery. It suggests that using a standardized nomenclature can facilitate international collaborative studies all over the world. The INRGSS broadly classifies NB into localized and metastatic cases (7) . Aim: This study aims to stage neuroblastoma cases using CT scan according to the INRGSS, in relation to available clinicopathologic data.
excluded from the study. The study was approved by the Ethics Board of Ain Shams University. . 3-For cases having available post-surgical scans, the INSS was also used for staging (6) , in addition to theINRGSS staging system (table 2).
METHODS

1-
4-The study was approved by the Ethics Board of Ain
Shams University. 
RESULTS
I-Clinicopathologic Results
The age ranged from 1 to 10 years, with a mean of 3.40 (3.40 ± 2.21)and a median age of 3 years. Mostcases (18/20) were ˃ 1 year (90%) and only 2/20 were aged 1year (10%).Out of the 20 patients, 10 were males (50%) and 10 were females (50%), with a M: F ratio of 1:1. The Shimada classification for pathologic diagnosis and grading of NB was used (table 3) . Among 20 cases, 17 were poorly differentiated (85%) and only 3 were well differentiated.
Immunohistochemical confirmation of diagnosis was also reported. All 20 cases were positive for synoptophysin and negative for Desmin and leucocyte common antigen (LCA). Presenting symptom was abdominal distension in the abdomen (15/20cases) noticed by parents. Fever and generalized weakness was reported in 3 and 2 cases respectively. The most common clinical finding was abdominal mass in 17 cases (85%). One case was a retroperitoneal mass, 1 presacral mass and one had a large hepatic mass, metastatic at initial presentation.
II-CT Radiologic Results
1-Site of Tumor
The suprarenal gland was the primary site of origin in 10 patients (50%), 6 were on the left. There were 5 cases of abdominal origin (25%).Site of all cases is shown in table 4. 
4-Metastatic Spread
It was found that 13 cases were free from metastatic spread (65%). Tumor metastasis was noted in7 cases (35%).
Brain metastasis was present in 2. Other metastatic sites are shown in table 7, including liver, skull and skin. 
5-Image Defined Risk Factors
To allow accurate staging according to the INRGSS, cases were analyzed for presence or absence of the different IDRFs.
Vascular encasement was noted in 11 (55%). Infiltration to nearby vital structures was present in 5 cases (25%). Invasion to one or both renal pedicles was evident in 10/20 cases (50%). Contact to head of pancreas was found in only 1 case (5%). However, compression to airways was not applicable in all studied cases (table 8, fig1). 
DISCUSSION
The International Neuroblastoma Risk Group Staging System (7) (INRGSS) is a recent staging system for NB, based on the imaging results taken before surgery or any other treatment.
The present study was conducted on 20 neuroblastoma cases in the pediatric age group. Staging for all cases was done according to the INRGSS. The INSS was also used to stage 7 cases having available postsurgical CT scans.
Regarding the clinicopathologic characteristics of the 20 studied cases, the age ranged from 1 to 10 years with a mean age of 3.4 years and a median of 3 years. This in accordance with other studies (8) . The majority of cases in the present work were ˃ 1 year (90%) and none of the cases was above 10 years. It was reported that 98% of NB cases were less than 10 years (9) .Also, in Egyptian studies, it was found that 77.4% and 95% of NB cases were ˃ 1 year respectively (8) (10) .There were 10 males and 10 females, with a M: F ratio of 1:1. Other studies reported that NB was slightly more common in males than females with a ratio of 1.1:1 (8, 9) . According to the Shimada classification, the majority of cases were poorly differentiated (17/20cases, 85%). Immunohistochemical confirmation of NB diagnosis showed that all cases were positively stained for synaptophysin, indicating presence of neurofilaments, and negative for desmin and LCA excluding diagnosis of rhabdomyosarcoma and lymphoma respectively (1) . The most common clinical presentation in this study (17/20 cases, 85%) was an abdominal mass. As demonstrated in CT scans, the majority of tumors were in the adrenal gland (10/20 cases, 50%) and abdomen (5/20 cases, 25%). This is similar to results of other studies (3) (11) .However, another study reported that 70% of cases were of abdominal origin (12) . In the present study, 14/20 cases (70%) were seen on CT scans as heterogeneous masses, 7 of which having calcifications (35%). This is in accordance to previous studies describing NB as large lobulated heterogeneous mass (5) . The presence of calcifications favors the diagnosis of NB; it was reported in 85% of abdominal cases (13) . This higher percentage than the present study is due to larger number of cases studied.
In this study, 14/20 cases (70%) had positive nodal affection including regional and distant LNs. Distant metastasis was present in 7/20 cases (35%) including brain, hepatic, skull, dural and skin metastasis. About 50-60% of neuroblastomas were reported to have nodal or distant metastasis (9) .Also; another study reported that regional LN affection and metastatic spread was found in 35% and 50 % of studied cases respectively (14) . IDRFs are important, as they define the anatomic extent of NB, and its relation to adjacent vital structures (vessels and nerves) or organs (12) (15) . In this work, only 1/20 cases (5%) showed contact with the head of pancreas, with no visible layer between the tumor and pancreas. Contact is not considered an IDRF. Encasement was found in 11/20 cases (55%). In these cases, contact between the affected vessels and the tumor involved more than 50% of its circumference (15) . Infiltration of neighboring structures was detected in 5/20 cases (25%). It affected the pancreas, the liver, the hepatoduodenal ligament or diaphragm. An infiltrating tumor extends into an adjacent organ, with absence of margins between them (15) . Invasion of one or both renal pedicles was evident in 10/20 cases (50%).Due to difficult dissection of the renal pedicle during surgery; this risk factor was considered present even with presence of contact only between the tumor and the renal vessels (15) . All these IDRFs are similar to those of previous studies, but with much higher frequency which is explained by late stage presentation and lower number of cases included in this work. Other studies reported vascular encasement in 21% and 13%, invasion of renal pedicles in 5 % and 9% and infiltration of adjacent organs in 7% and 9% respectively (16) (17) . In this study, Stage L2 was the most commonly found, 9/20 cases (45%) had locoregional tumor with presence of 1 or more IDRFs. Stage M followed, 7/20 cases (35%) involved distant metastasis. L1 was found in 3 cases (15%), with localized tumor confined to 1 body compartment without any IDRFs, LNs or metastatic spread. (18) . It was reported in several studies that INRGSS is a standardized approach, facilitating collaborative studies between different centers and comparison of patient outcome of different treatment protocols, which was not possible when using the INSS (17) (19) . Both INSS and INRGSS were found to be highly prognostic. The INRGSS is much more reliable in comparison to the risk based clinical trials. The limitation of this staging system is that it cannot be applied post-treatment (7) .
CONCLUSION
The use of the INRGSS is a recent valuable pretreatment staging system for neuroblastoma, allowing accurate classification depending on the presence or absence of IDRFs. It is not intended to replace the INSS but can be used in parallel. Imaging by CT scan plays an important role in diagnosis and staging of neuroblastoma. However, further researches on a larger scale are needed to allow more accurate and detailed information about the value of the INRGSS in Egyptian neuroblastoma cases, with correlation to patient outcome.
